Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-21 Sale |
2025-01-23 5:18 pm |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph Chief Executive Officer |
12,619 | $1.593 | $20,102 | 667,488 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:09 pm |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph Chief Executive Officer |
47,778 | $1.8392 | $87,873 | 1,018,107 (Direct) |
View |
| 2024-01-19 Sale |
2024-01-19 7:07 pm |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
15,200 | $3.4706 | $52,753 | 502,485 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-07 Option Award |
2025-01-07 8:09 pm |
N/A 2035-01-07 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph Chief Executive Officer |
563,400 | $0 | 1,018,107 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:18 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
1,003,000 | $0 | 1,119,685 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-18 4:22 pm |
N/A 2033-01-16 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
586,500 | $0 | 589,185 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:20 pm |
N/A 2032-01-19 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
455,000 | $0 | 455,000 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 4:41 pm |
N/A 2021-12-01 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
1,118 | $0 | 2,685 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 4:41 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
1,118 | $4.47 | 2,685 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:16 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
123 | $0 | 1,567 (Direct) |
View |
| 2021-07-06 Tax Withholding |
2021-07-08 6:16 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
10 | $16 | 1,567 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 6:16 pm |
2020-12-31 2025-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
35 | $0 | 1,567 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 6:16 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
35 | $4.47 | 1,567 (Direct) |
View |
Ownership |
2021-06-30 6:51 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
0 | $0 | 1,654,235 (Direct) |
View |